Australia's China problem is not the retail pack. In 2024 HS 30 imports were 11,107,115.77 thousand U.S. dollars. The United States was 2,487,872.49. Germany was 1,486,943.53. Ireland was 855,198.15. Belgium was 834,596.56. Switzerland was 722,794.29. India was 532,337.00. China was 196,970.49. Calculated from the printed thousand-dollar values, the United States was 22.4 percent of pharmaceutical-product import value. Calculated from the printed thousand-dollar values, Germany was 13.4 percent of pharmaceutical-product import value. Calculated from the printed thousand-dollar values, China was 1.8 percent of pharmaceutical-product import value. Calculated from the printed thousand-dollar values, India was 4.8 percent of pharmaceutical-product import value. The United States, Germany, Ireland, Belgium, Switzerland, and India are the non-China lines on this table.
wits.worldbank.org
Finished doses, HS 3004, were 6,121,494.85 thousand U.S. dollars. The United States was 891,071.91. Germany was 765,481.65. Ireland was 606,502.55. India was 520,104.75. China was 68,361.06 thousand dollars and 399,943 kilograms. Calculated from the printed thousand-dollar values, the United States was 14.6 percent of finished-dose import value. Calculated from the printed thousand-dollar values, Germany was 12.5 percent of finished-dose import value. Calculated from the printed thousand-dollar values, Ireland was 9.9 percent of finished-dose import value. Calculated from the printed thousand-dollar values, India was 8.5 percent of finished-dose import value. Calculated from the printed thousand-dollar values, China was 1.1 percent of finished-dose import value. A China customs stop removes a small finished-dose line. The invoice leaders are not China.
wits.worldbank.org
Antibiotics are the China-concentrated slice. HS 2941 world imports were 38,886.99 thousand U.S. dollars. China was 14,331.37 thousand dollars and 265,342 kilograms. India was 7,435.76 thousand dollars and 36,975 kilograms. France was 4,231.12. Italy was 3,991.31. The United States was 3,468.83. World kilograms are blank on the page, so no weight share is calculated. Calculated from the printed thousand-dollar values, China was 36.9 percent of antibiotic import value. Calculated from the printed thousand-dollar values, India was 19.1 percent of antibiotic import value. India, France, Italy, and the United States are the non-China antibiotic lines. None of them is larger than China on this table.
wits.worldbank.org
The payer and the pharmacy are the Australian cash nodes, not a domestic finished-dose census. No ABS manufacturing output for pharmaceuticals was on the pages opened. Government expenditure was $19.1 billion for PBS medicines in 2024-25, 91.7% of total medicine costs, and was up 7.4% from 2023-24. Patients contributed $1.7 billion. Community pharmacies dispensed around 327.2 million prescriptions. There are 6,013 community pharmacies. Public hospitals: there were 703 public hospitals and 68,200 public hospital beds in 2024-25.
pbs.gov.auguild.org.auaihw.gov.au
The domestic product that the stockpile page says can be made in Australia is pandemic influenza vaccine, through a long-term arrangement with CSL Seqirus, and only if a pandemic is declared. The stockpile is not a general medical supply service. Quantities are not printed. That is not a buffer for the PBS formulary.
health.gov.au
Low-exposure proof. No opened Australian WITS partner table for HS 30, HS 3004, HS 3003, or HS 2941 names Taiwan. No Taiwan medicine row is filled. A foundry-revenue share is not a medicine share and is not used. A chip or excipient share inside a dose stays unpublished.
wits.worldbank.orgwits.worldbank.org
Step 1, the finished-dose invoice stays with other partners. China was 1.1 percent of finished-dose import value on the calculation above, equal to 68,361.06 thousand dollars. The United States, Germany, Ireland, and India are the four largest HS 3004 origins. A China stop does not, on this table, remove those four.
wits.worldbank.org
Step 2, antibiotics and a slice of bulk medicaments are the China lines. China was 36.9 percent of antibiotic import value. China was 15.4 percent of bulk-medicament import value. France, Italy, the United States, and India remain on the antibiotic page. Italy remains the bulk leader at 20,814.51 thousand dollars. They are continuations in the customs sense. They are not printed as volume replacements for the China line.
wits.worldbank.orgwits.worldbank.org
Step 3, Indian finished doses are a real Australian origin, at 520,104.75 thousand dollars of HS 3004, and they are not a clean API substitute. Brookings, writing about the U.S. generic market and India's trade statistics, says the dollar share of Chinese imports relative to all API India imports has been hovering around 68% plus or minus 2%. That 68% figure is not an Australian customs share. It is the upstream limit on treating Indian packs as China-free.
wits.worldbank.orgbrookings.edu
Step 4, Taiwan. The four opened 2024 Australian WITS partner tables do not name Taiwan. No PBS, AIHW, Guild, or stockpile page opened here prints a Taiwan medicine quantity. The scenario's Taiwan export restriction is an explicit limit for this industry.
wits.worldbank.orgwits.worldbank.orgwits.worldbank.orgwits.worldbank.org
Step 5, the cash path is PBS claiming, not a domestic plant census. As of 30 June 2025, 99.9% of approved suppliers of PBS or RPBS medicines used online claiming. A claiming outage stops payment in the same week the terminals stop. That is the short-horizon operational fact. It is not a printed outage duration.
guild.org.au
Step 6, hospitals and the stockpile. In 2024-25 there were 703 public hospitals and 68,200 public hospital beds. In 2023-24, $113.8 billion was spent on hospital care, of which $90.8 billion was public hospitals and $23.0 billion was private hospitals. The stockpile holds specialised medicines and pandemic influenza antivirals and can direct CSL Seqirus to manufacture pandemic influenza vaccine if a pandemic is declared. Requests go through the state or territory Chief Health Officer. It is not a general supply for a China antibiotic stop.
aihw.gov.auhealth.gov.au